2013•Tianjin Journal of Traditional Chinese MedicineRequires access

Clinical observation on Shenkang injection in treating diabetic renopathy in early period

MA Ji-we

Open publisher page 0 citations

Abstract

[Objective] To investigate the therapeutic effect of Shenkang injection on diabetic kidney disease in early period.[Methods] The patients were randomly divided into treatment group(36 cases) and control group(40 cases).Both groups were given quality diet with low protein.Blood pressure and plasma glucose were controlled.In addition,the patients in treatment group were given with shenkang injection,100 mL/d for four weeks.Fasting blood glucose(FBG),2-hour postprandial glucose(PBG),triglyceride(TG),total cholesterol(TC),blood fibrinogen(Fg),α-microglobulin(α-MG),twenty-four-hour urine protein quantitation(24 h UP),NAG and UAER were examined.[Results] Compared with those in control group,the amount of FBG,PBG,TG,TC,Fg,α-MG,NAG,UAER and 24-hour urine protein were markedly decreased in treatment group(P0.05).[Conclusion] Shenkang injection can delay the development of diabetic renopathy.

About this research paper

What this paper is about

[Objective] To investigate the therapeutic effect of Shenkang injection on diabetic kidney disease in early period.[Methods] The patients were randomly divided into treatment group(36 cases) and control group(40 cases).Both groups were given quality diet with low protein.Blood pressure and plasma glucose were controlled.In addition,the patients in treatment group were given with shenkang injection,100 mL/d for four weeks.Fasting blood glucose(FBG),2-hour postprandial glucose(PBG),triglyceride(TG),total cholesterol(TC),blood fibrinogen(Fg),α-microglobulin(α-MG),twenty-four-hour urine protein quantitation(24 h UP),NAG and UAER were examined.[Results] Compared with those in control group,the amount of FBG,PBG,TG,TC,Fg,α-MG,NAG,UAER and 24-hour urine protein were markedly decreased in treatment group(P0.05).[Conclusion] Shenkang injection can delay the development of diabetic renopathy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

[Objective] To investigate the therapeutic effect of Shenkang injection on diabetic kidney disease in early period.[Methods] The patients were randomly divided into treatment group(36 cases) and control group(40 cases).Both groups were given quality diet with low protein.Blood pressure and plasma glucose were controlled.In addition,the patients in treatment group were given with shenkang injection,100 mL/d for four weeks.Fasting blood glucose(FBG),2-hour postprandial glucose(PBG),triglyceride(TG),total cholesterol(TC),blood fibrinogen(Fg),α-microglobulin(α-MG),twenty-four-hour urine protein quantitation(24 h UP),NAG and UAER were examined.[Results] Compared with those in control group,the amount of FBG,PBG,TG,TC,Fg,α-MG,NAG,UAER and 24-hour urine protein were markedly decreased in treatment group(P0.05).[Conclusion] Shenkang injection can delay the development of diabetic renopathy.

Key concepts: Postprandial, Medicine, Internal medicine, Urine, Triglyceride, Endocrinology, Urology, Fibrinogen

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical observation on Shenkang injection in treating diabetic renopathy in early period — Research Paper | ScholarLens